Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infectionsSebastian Schneeweiß, Brian Bressler, Joshua R. Korzenik et al.|Alimentary Pharmacology & Therapeutics|2009Cited by 214
International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow upRuqaiah Altassan, Mari‐Anne Vals, Romain Péanne et al.|Journal of Inherited Metabolic Disease|2019Cited by 149
SLC35A2‐CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported IndividualsBobby G. Ng, María J. Guillen Sacoto, Paulina Sosicka et al.|Human Mutation|2019Cited by 67
International consensus guidelines for phosphoglucomutase 1 deficiency (<scp>PGM1‐CDG</scp>): Diagnosis, follow‐up, and managementRuqaiah Altassan, Éva Morava, Silvia Radenkovic et al.|Journal of Inherited Metabolic Disease|2020Cited by 66
Ethylmalonic encephalopathy masquerading as meningococcemiaAri Horton, Michael Fahey, C. J. Killick et al.|Molecular Case Studies|2022Cited by 4